Week 3 HW: CELL FREE PROTOCOLS

K-glutamate and Mg-glutamate have different roles in cell-free protein synthesis.

K-glutamate mainly provides potassium ions and helps establish the ionic environment of the reaction. Potassium concentration affects ribosome function, enzyme activity, nucleic-acid interactions, and the overall physiological-like environment of the lysate.

Mg-glutamate provides magnesium ions. Magnesium is especially important because it interacts with ATP and other nucleotides and is required for proper ribosome structure and function. However, the free Mg²⁺ concentration is strongly affected by other negatively charged molecules in the reaction, including ATP, nucleic acids, and phosphate-containing compounds.

The two concentrations therefore cannot be treated independently. Changing Mg-glutamate can strongly affect translation because too little Mg²⁺ can reduce ribosome stability and activity, while too much can also inhibit protein synthesis. K-glutamate mainly tunes the ionic environment and has a broader acceptable range around the optimum.

In the optimization experiments of Jewett and Swartz (2004), both K-glutamate and Mg-glutamate affected protein synthesis, but the Mg-glutamate response was particularly important because magnesium directly interacts with nucleotides and the ribosome. Mg-glutamate is therefore generally the more sensitive component to optimize carefully, while K-glutamate is used to establish the appropriate overall ionic strength. This is also why CFPS formulations often keep Mg²⁺ in a relatively narrow range while adjusting K-glutamate over a broader range. The true optimum can also depend on the lysate batch and other components present.

The two systems regenerate the nucleotide triphosphates required for transcription and translation using different strategies.

PEP + NTP system: the reaction is supplied directly with ATP, GTP, CTP, and UTP, which are required for RNA synthesis (ATP also supports general energy metabolism). Phosphoenolpyruvate (PEP) acts as a high-energy phosphate donor, regenerating ATP from ADP so transcription and translation can continue. This is a straightforward, well-established approach that gives strong protein production, but PEP is relatively expensive, and phosphate byproducts can accumulate during the reaction, eventually inhibiting the system or shifting pH. Jewett and Swartz specifically identified the cost and accumulation of inhibitory phosphate as limitations of this strategy.

Ribose + NMP system: instead of supplying NTPs directly, the reaction supplies ribose plus nucleoside monophosphates (AMP, CMP, GMP, UMP). The lysate’s own metabolic enzymes regenerate the needed NTPs from these cheaper precursors. This can substantially reduce reagent cost, since NMPs and ribose are less expensive than purified NTPs. Olsen et al. (2026) demonstrated that CFPS can generate NTPs from nitrogenous bases and ribose, achieving high protein yields while substantially reducing reagent cost.

In short: PEP + NTP is a strong conventional starting point; Ribose + NMP is attractive specifically for cost optimization and metabolic recycling. The best choice depends on the lysate, target protein, and the desired balance between yield and cost.

Formulation 1 — PANOx-SP (Jewett & Swartz, 2004)

A representative PANOx-SP-family formulation contains approximately:

• K-glutamate: ~130–175 mM
• Mg-glutamate: ~16–20 mM
• Ammonium glutamate: ~10 mM
• PEP: ~30–33 mM
• ATP: ~1.2 mM
• GTP, CTP, UTP: ~0.85 mM each
• Amino acids: ~2 mM each
• Spermidine: ~1–1.5 mM
• Putrescine: ~1 mM
• NAD, CoA, folinic acid, oxalate

Jewett and Swartz developed this general Cytomim/PANOx family to provide a stable metabolic environment for CFPS. Later PANOx-SP formulations became a widely used high-performing reference system.

Formulation 2 — Olsen et al. (2026), RFopt

Olsen et al. developed a substantially more cost-optimized formulation by screening 58 reagent components across 1,231 different reaction combinations. Their final optimized formulation (RFopt) uses just 12 components — a major simplification compared to PANOx-SP — and moves away from expensive phosphorylated energy substrates.

Note on specific yield/cost figures: I was not able to independently verify an exact $/g or g/L figure for RFopt beyond the paper’s reported 84–99% cost reduction (averaging ~95%) compared to state-of-the-art phosphorylated-energy formulations. I’m citing that averaged figure here since I could confirm it, rather than a specific $/g number I could not verify — worth double-checking against the actual PDF in the course drive folder if an exact per-gram cost is needed.

The RFopt strategy uses components including higher K-glutamate, Mg-glutamate, amino acids, potassium phosphate, ribose, glucose, nicotinamide, and nucleoside monophosphates (AMP, CMP, GMP, UMP) — rather than the PEP + direct-NTP combination used in PANOx-SP.

Comparison

The main difference is the energy and nucleotide regeneration strategy: PANOx-SP prioritizes a well-established, direct system with PEP and supplied NTPs, while RFopt prioritizes cost reduction and metabolic recycling, using cheaper precursors and fewer total components.